CN104800836B - A kind of Isin glue collagen and its production method and application - Google Patents

A kind of Isin glue collagen and its production method and application Download PDF

Info

Publication number
CN104800836B
CN104800836B CN201510262006.0A CN201510262006A CN104800836B CN 104800836 B CN104800836 B CN 104800836B CN 201510262006 A CN201510262006 A CN 201510262006A CN 104800836 B CN104800836 B CN 104800836B
Authority
CN
China
Prior art keywords
parts
root
chinese medicine
weight
medicine preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201510262006.0A
Other languages
Chinese (zh)
Other versions
CN104800836A (en
Inventor
李宗宝
尤从伟
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Xinyuhui Biotechnology Shandong Co ltd
Original Assignee
Xin Yuhui Bio Tech Ltd Linyi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Xin Yuhui Bio Tech Ltd Linyi filed Critical Xin Yuhui Bio Tech Ltd Linyi
Priority to CN201510262006.0A priority Critical patent/CN104800836B/en
Publication of CN104800836A publication Critical patent/CN104800836A/en
Application granted granted Critical
Publication of CN104800836B publication Critical patent/CN104800836B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

本发明涉及一种鱼胶原蛋白及其生产方法和应用,其鱼骨胶原蛋白、硫酸软骨素、中药制剂按照10:3:2的重量比混合均匀;所述中药制剂由下述配比的原料制备而得:银杏叶、熟地、乳香、桑椹子、鹿角胶、鸡血藤、补骨脂、茯苓、白术、蒲公英、四季青、黄芪、枸杞子、何首乌、山药、党参、川芎、刺五加、葛根、杜仲、牛膝、陈皮、芡实、淫羊藿。本发明生产的蛋白粉各原料互作配伍,能发挥其协同作用,适用于骨质疏松症,前景广阔。This invention relates to a fish collagen protein, its production method, and its applications. The fish bone collagen protein, chondroitin sulfate, and a traditional Chinese medicine preparation are mixed uniformly in a weight ratio of 10:3:2. The traditional Chinese medicine preparation is prepared from the following raw materials in the specified proportions: ginkgo leaves, rehmannia root, frankincense, mulberry fruit, deer antler glue, chicken blood vine, psoralea corylifolia, poria cocos, atractylodes macrocephala, dandelion, holly, astragalus root, wolfberry fruit, fleeceflower root, yam, codonopsis root, chuanxiong rhizome, eleutherococcus senticosus, kudzu root, eucommia bark, achyranthes root, tangerine peel, euryale seed, and epimedium. The protein powder produced by this invention exhibits synergistic effects from the various raw materials, making it suitable for osteoporosis and showing promising prospects.

Description

一种鱼胶原蛋白及其生产方法和应用A kind of fish collagen and its production method and application

技术领域technical field

本发明涉及药物领域,涉及一种鱼胶原蛋白,特别涉及以鱼骨胶原蛋白为主要原料的鱼胶原蛋白粉及其生产方法和应用。The invention relates to the field of medicines, in particular to fish collagen, in particular to fish collagen powder with fish bone collagen as the main raw material and its production method and application.

背景技术Background technique

骨质疏松即骨质疏松症,是多种原因引起的一组骨病,骨组织有正常的钙化,钙盐与基质呈正常比例,以单位体积内骨组织量减少为特点的代谢性骨病变。在多数骨质疏松中,骨组织的减少主要由于骨质吸收增多所致。以骨骼疼痛、易于骨折为特征。其为当今世界上最突出的社会问题和医学问题之一,已引起联合国和世界各国的广泛关注。骨质疏松症可导致骨量减少和骨强度下降,再受轻微外力或其他因素影响,即可发生骨折,称骨质疏松性骨折。我国是世界上老年人口最多的国家。目前60岁以上老人超过1.8亿,占总人口的13%,已快速进入人口老龄化社会,由人口老龄化社会所致的骨质疏松症、骨质疏松性骨折患者, 2000年8400万人;2010年1.4亿人,占总人口的7.9%,发病率呈明显递增趋势。Osteoporosis, or osteoporosis, is a group of bone diseases caused by a variety of reasons. Bone tissue has normal calcification, and the ratio of calcium salt to matrix is normal. It is a metabolic bone lesion characterized by a decrease in the amount of bone tissue per unit volume. . In most cases of osteoporosis, the loss of bone tissue is mainly due to increased bone resorption. Characterized by bone pain and susceptibility to fractures. It is one of the most prominent social and medical problems in the world today, and has attracted widespread attention from the United Nations and countries around the world. Osteoporosis can lead to decreased bone mass and bone strength, and then affected by slight external force or other factors, fractures can occur, which are called osteoporotic fractures. my country is the country with the largest elderly population in the world. At present, there are more than 180 million people over the age of 60, accounting for 13% of the total population, and have rapidly entered the population aging society. The number of patients with osteoporosis and osteoporotic fractures caused by the population aging society was 84 million in 2000; In 2010, there were 140 million people, accounting for 7.9% of the total population, and the incidence rate showed an obvious increasing trend.

骨质疏松症、骨质疏松性骨折主要临床表现:腰膝酸软,小腿抽筋,骨骼疼痛,身体缩短,驼背畸形,脊柱侧弯,不耐劳累,四肢乏力,虚热盗汗等。严重者胸廓畸形,胸腔变小,甚至出现胸闷、气短、紫绀、呼吸困难等症状。其临床特点:患者年龄大,体质弱,症状重,合并症多,疗程长,功能恢复差,致残率高,死亡率高。轻微外伤可致脊柱压缩骨折,髋部骨折,桡骨远端骨折,肱骨近端骨折,肱骨远端骨折,踝部骨折,胫骨平台骨折,股骨远端骨折等。因活动减少或长期卧床,容易发生肺部感染,泌尿系统感染,压疮,下肢深静脉血栓形成,肺栓塞,多器官功能衰竭等严重并发症而死亡。不仅给患者和家庭带来了肉体上和精神上的巨大痛苦,还给患者和家庭带来了治疗费用的巨大开支和沉重的经济负担。The main clinical manifestations of osteoporosis and osteoporotic fractures: weakness of waist and knees, calf cramps, bone pain, shortened body, kyphosis, scoliosis, intolerance to fatigue, weakness of limbs, night sweats due to deficiency heat, etc. In severe cases, the thorax deforms, the chest becomes smaller, and even symptoms such as chest tightness, shortness of breath, cyanosis, and dyspnea appear. Its clinical characteristics: the patients are old, weak in constitution, with severe symptoms, many complications, long course of treatment, poor functional recovery, high disability rate and high mortality rate. Minor trauma can cause spinal compression fractures, hip fractures, distal radius fractures, proximal humerus fractures, distal humerus fractures, ankle fractures, tibial plateau fractures, and distal femur fractures. Due to reduced activity or long-term bed rest, lung infection, urinary system infection, pressure sore, deep vein thrombosis of lower extremities, pulmonary embolism, multiple organ failure and other serious complications are prone to death. It not only brings great physical and mental pain to patients and families, but also brings huge expenses of treatment costs and heavy economic burden to patients and families.

西医治疗方面:一些一线专用药物治疗周期长,见效慢,副作用大;某些新药治疗效价比不合理,限制条件多,服药依从性低;骨质疏松性骨折手术治疗风险大,并发症多,费用昂贵等诸多因素。使部分患者接受了不规范的治疗,甚至选择了中断治疗或放弃治疗,出现了临床治疗过程中患者骨量继续减少,骨强度持续下降,轻微外力可致骨折发生或再骨折的“返贫”现象,使患者致残率和死亡率明显增加。严重影响了全民防治骨质疏松工程进展和全民健康规划实施,加重了人口老龄化社会的热点突出问题。In terms of Western medicine treatment: some first-line special drugs have a long treatment cycle, slow effect, and large side effects; some new drugs have unreasonable therapeutic efficacy, many restrictions, and low compliance with medication; surgical treatment of osteoporotic fractures has high risks and many complications , expensive and many other factors. Some patients received irregular treatment, and even chose to interrupt treatment or give up treatment. During the course of clinical treatment, the patient's bone mass continued to decrease, bone strength continued to decline, and slight external force could cause fracture or re-fracture. "Returning to poverty" phenomenon , significantly increasing the morbidity and mortality of patients. Seriously affected the progress of the national osteoporosis prevention and control project and the implementation of the national health plan, and aggravated the hot and prominent issues in the population aging society.

发明内容Contents of the invention

本发明的目的是为了克服背景技术的不足,结合大量祖方及自己多年的医疗实践,通过对传统中药的研究,并结合辩证论证,多方收集众家之长,寻求最佳治疗方案,根据唯物辩证法的哲学思想和中医学 “肾主骨,藏精,生骨髓”;“肝主筋,藏血,主疏泄”;“脾主化运水谷之精,以生养肌肉”。“虚劳”、“肾虚”、“肾虚则骨失所养至骨痿则骨痛”;“肝肾脾虚”,“则腰脊不举,骨枯而髓少,发为骨痿”,“其筋骨不荣”,“易骨折”。“肾实则骨有生气”,“骨髓生化有源,骨骼滋养充足,坚固而有力”。“气为血之帅,血为气之母”,“气滞则血瘀,气行则血行”;“气以行为尊,血以活为贵”;“不通则痛,通则不痛”;“结则散之”,“损则益之”,“虚则补之”;“瘀去、新生、骨合”。“治未病”等重要基础理论。坚持补肾养肝,兼及五脏;滋阴温阳,气血双补;津液和调,补髓生骨;标本兼治。The purpose of the present invention is to overcome the deficiencies in the background technology, combine a large number of ancestral prescriptions and one's own medical practice for many years, through the research on traditional Chinese medicine, combined with dialectical argumentation, collect the strengths of many families, seek the best treatment plan, according to materialistic The philosophy of dialectics and traditional Chinese medicine "kidney governs bones, stores essence, and produces bone marrow"; "liver governs tendons, stores blood, and governs catharsis"; "Asthenia", "kidney deficiency", "kidney deficiency leads to bone loss and bone atrophy, resulting in bone pain"; disgraceful", "easy to fracture". "Kidneys are vital to the bones", "Bone marrow is biochemically active, and the bones are well nourished, strong and powerful". "Qi is the master of blood, blood is the mother of qi", "qi stagnation leads to blood stasis, qi flow leads to blood flow"; "qi is respected by behavior, and blood is valued by life"; "Consolidation will dissipate it", "loss will benefit it", "deficiency will replenish it"; "stasis removal, regeneration, bone union". "preventive treatment of disease" and other important basic theories. Insist on nourishing the kidney and nourishing the liver, and the five internal organs; nourishing yin and warming yang, nourishing both qi and blood; harmonizing body fluid, nourishing marrow and promoting bone; treating both symptoms and root causes.

为实现上述目的,本发明采用的技术方案如下:To achieve the above object, the technical scheme adopted in the present invention is as follows:

一种以鱼胶原蛋白为主成分的用于骨质疏松的蛋白粉,其由鱼骨胶原蛋白粉、硫酸软骨素粉、中药制剂按照10:3:2的重量比混合均匀;A protein powder for osteoporosis with fish collagen as the main component, which is uniformly mixed with fish bone collagen powder, chondroitin sulfate powder, and traditional Chinese medicine preparations in a weight ratio of 10:3:2;

所述中药制剂由下述配比的原料制备而得:The traditional Chinese medicine preparation is prepared from the following raw materials:

银杏叶、熟地黄、乳香、桑椹子、鹿角胶、鸡血藤、补骨脂、茯苓、白术、蒲公英、四季青、黄芪、枸杞子、何首乌、山药、党参、川芎、刺五加、葛根、杜仲、牛膝、陈皮、芡实、淫羊藿。Ginkgo biloba, rehmannia glutinosa, frankincense, mulberry, staghorn gum, Millet Spatholobus, psoralen, Poria cocos, Atractylodes macrocephala, dandelion, Sijiqing, astragalus, medlar, Polygonum multiflorum, Chinese yam, Codonopsis pilosula, Chuanxiong, Acanthopanax, Pueraria, Eucommia, Achyranthes bidentata, Chenpi, Gorgon, Epimedium.

优选地,所述中药制剂由下述重量配比的原料制备而得:Preferably, the traditional Chinese medicine preparation is prepared from the following raw materials in weight ratio:

银杏叶35份、熟地黄35份、乳香35份、桑椹子35份、鹿角胶30份、35 parts of ginkgo leaves, 35 parts of Rehmannia glutinosa, 35 parts of frankincense, 35 parts of mulberries, 30 parts of antler gum,

鸡血藤30份、补骨脂30份、茯苓30份、白术28份、蒲公英28份、30 parts of Caulis Spatholobus, 30 parts of Psoralen, 30 parts of Poria cocos, 28 parts of Atractylodes macrocephala, 28 parts of dandelion,

四季青25份、黄芪25份、枸杞子25份、何首乌25份、山药22份、25 parts of Sijiqing, 25 parts of Astragalus membranaceus, 25 parts of medlar, 25 parts of Polygonum multiflorum, 22 parts of Chinese yam,

党参20份、川芎20份、刺五加20份、葛根15份、杜仲15份、Codonopsis 20, Chuanxiong 20, Acanthopanax 20, Pueraria 15, Eucommia 15,

牛膝10份、陈皮10份、芡实10份、淫羊藿10份。10 parts of Achyranthes knuckles, 10 parts of tangerine peel, 10 parts of gorgon, 10 parts of epimedium.

所述中药制剂的制备方法如下:The preparation method of described Chinese medicine preparation is as follows:

按照上述重量称取上述原料药备用:Take by weighing above-mentioned crude drug according to above-mentioned weight for subsequent use:

(1)取银杏叶、四季青、黄芪、何首乌、党参、芡实、淫羊藿按所述比例混合,加相对于混合物3倍重量95%的乙醇(体积比),回流提取2次,每次0.5小时,提取液合并,浓缩至密度为1.2g/ml的清膏,80℃烘干,粉碎成粉末;(1) Take Ginkgo biloba leaves, Sijiqing, Astragalus, Polygonum multiflorum, Codonopsis pilosula, Gorgon fruit, and Epimedium and mix them according to the stated ratio, add 95% ethanol (volume ratio) relative to 3 times the weight of the mixture, and reflux extraction twice, each time After 0.5 hours, the extracts were combined, concentrated to a clear paste with a density of 1.2g/ml, dried at 80°C, and crushed into powder;

(2)取剩余成分加3倍重量水煎煮两次,第一次2小时,第二次1小时(同样加3倍重量的水),合并两次煎煮液,减压干燥获得密度为1.2g/ml的浸膏,粉碎成粉末;(2) Take the remaining ingredients and add 3 times the weight of water to decoct twice, the first time for 2 hours, and the second time for 1 hour (also add 3 times the weight of water), combine the two decoctions, dry under reduced pressure to obtain a density of 1.2g/ml extract, crushed into powder;

(3)将步骤(1)和步骤(2)制备的粉末混合均匀即得。(3) Mix the powder prepared in step (1) and step (2) evenly.

用量:蛋白粉每次3克,每日3次,一个月为一个疗程,连续服用1-3个疗程。Dosage: 3 grams of protein powder each time, 3 times a day, one month is a course of treatment, 1-3 courses of treatment are taken continuously.

骨骼中有机物的70—80%是胶原蛋白,骨骼生成时,首先必须合成充足的胶原蛋白纤维来组成骨骼的框架,且胶原蛋白的氨基酸、羟基脯氨酸是血浆中运输钙到骨细胞的运载工具,骨细胞中的骨胶原是羟基磷酸钙的黏合剂。它与羟基磷酸钙共同构成了骨骼的主体。人进入中老年后,骨骼里的胶原蛋白质量越来越差,数量越来越少,不能有效地把所有的羟基磷酸钙黏合起来,这时就会发生骨质疏松,鱼胶原蛋白已被证实可经由口服而达到补充软组织结构的效果。70-80% of the organic matter in the bone is collagen. When the bone is formed, it must first synthesize enough collagen fibers to form the framework of the bone, and the amino acid and hydroxyproline of the collagen are the vehicles for transporting calcium to the bone cells in the plasma. Tool, collagen in bone cells is the binder of calcium hydroxyphosphate. Together with calcium hydroxyphosphate, it forms the main body of bone. When a person enters middle-aged and old age, the quality of collagen in the bone becomes worse and worse, and the amount becomes less and less. It cannot effectively bind all the calcium hydroxyphosphate together. At this time, osteoporosis will occur. Fish collagen has been proven The effect of replenishing soft tissue structure can be achieved by oral administration.

本发明将鱼胶原蛋白和中药制剂混合,经过合理的配伍,充分发挥了各原料自身的特有性能和功效,兼顾了彼此之间的互补作用;经过各原料相互之间的协同作用,其药效相辅相成,相互之间达到了最佳的匹配。The present invention mixes fish collagen and traditional Chinese medicine preparations, and through reasonable compatibility, fully exerts the unique performance and efficacy of each raw material itself, and takes into account the complementary effects between each other; through the synergistic effect of each raw material, its medicinal effect Complement each other and achieve the best match with each other.

本发明药物的组分均采用天然的中药原料,其配制简便,药源广泛,成本低廉,其遵循中医的处方用药原则,经临床应用验证,其疗效显著可靠,药性平和,未出现毒副作用,应用前景广阔。The components of the medicine of the present invention all adopt natural traditional Chinese medicine raw materials, which are easy to prepare, have a wide range of medicine sources, and are low in cost. The application prospect is broad.

具体实施方式detailed description

实施例1:Example 1:

一种鱼胶原蛋白,其由鱼骨胶原蛋白、硫酸软骨素、中药制剂按照10:3:2的重量比混合均匀;A fish collagen, which is uniformly mixed with fish bone collagen, chondroitin sulfate, and traditional Chinese medicine preparations in a weight ratio of 10:3:2;

所述中药制剂由下述重量配比的原料制备而得:The traditional Chinese medicine preparation is prepared from the following raw materials in weight ratio:

银杏叶35份、熟地35份、乳香35份、桑椹子35份、鹿角胶30份、35 parts of ginkgo leaves, 35 parts of Rehmannia glutinosa, 35 parts of frankincense, 35 parts of mulberries, 30 parts of antler gum,

鸡血藤30份、补骨脂30份、茯苓30份、白术28份、蒲公英28份、30 parts of Caulis Spatholobus, 30 parts of Psoralen, 30 parts of Poria cocos, 28 parts of Atractylodes macrocephala, 28 parts of dandelion,

四季青25份、黄芪25份、枸杞子25份、何首乌25份、山药22份、25 parts of Sijiqing, 25 parts of Astragalus membranaceus, 25 parts of medlar, 25 parts of Polygonum multiflorum, 22 parts of Chinese yam,

党参20份、川芎20份、刺五加20份、葛根15份、杜仲15份、Codonopsis 20, Chuanxiong 20, Acanthopanax 20, Pueraria 15, Eucommia 15,

牛膝10份、陈皮10份、芡实10份、淫羊藿10份。10 parts of Achyranthes knuckles, 10 parts of tangerine peel, 10 parts of gorgon, 10 parts of epimedium.

所述中药制剂的制备方法如下:The preparation method of described Chinese medicine preparation is as follows:

按照上述重量称取上述原料药备用:Take by weighing above-mentioned crude drug according to above-mentioned weight for subsequent use:

(1)取银杏叶、四季青、黄芪、何首乌、党参、芡实、淫羊藿按所述比例混合,加相对于混合物3倍重量95%的乙醇(体积比),回流提取2次,每次0.5小时,提取液合并,浓缩至密度为1.2g/ml的清膏,80℃烘干,粉碎成粉末;(1) Take Ginkgo biloba leaves, Sijiqing, Astragalus, Polygonum multiflorum, Codonopsis pilosula, Gorgon fruit, and Epimedium and mix them according to the stated ratio, add 95% ethanol (volume ratio) relative to 3 times the weight of the mixture, and reflux extraction twice, each time After 0.5 hours, the extracts were combined, concentrated to a clear paste with a density of 1.2g/ml, dried at 80°C, and crushed into powder;

(2)取剩余成分加3倍重量水煎煮两次,第一次2小时,第二次1小时(同样加3倍重量的水),合并两次煎煮液,减压干燥获得密度为1.2g/ml的浸膏,粉碎成粉末;(2) Take the remaining ingredients and add 3 times the weight of water to decoct twice, the first time for 2 hours, and the second time for 1 hour (also add 3 times the weight of water), combine the two decoctions, dry under reduced pressure to obtain a density of 1.2g/ml extract, crushed into powder;

(3)将步骤(1)和步骤(2)制备的粉末混合均匀即得。(3) Mix the powder prepared in step (1) and step (2) evenly.

用量:每次3克,每日3次,一个月为一个疗程,连续服用1-3个疗程。Dosage: 3 grams each time, 3 times a day, one month is a course of treatment, take 1-3 courses of treatment continuously.

实施例2Example 2

动物实验Animal experiment

实验动物BABc小鼠40只,雌雄各半,清洁级,体重20-22g,由市人民医院动物中心提供。随机分为4组,每组10只,即空白对照组1、模型对照组2、实施例1药物组3、对照药物组4。除1组给予生理盐水外,其余各组均给予地塞米松1mg/kg,每三天注射一次,肌肉注射,同时,联合维甲酸灌胃,每天用量70mg/kg,共三周。Experimental Animals 40 BABc mice, half male and half female, clean grade, weighing 20-22 g, were provided by the Animal Center of Municipal People's Hospital. They were randomly divided into 4 groups with 10 rats in each group, namely blank control group 1, model control group 2, drug group 3 of Example 1, and control drug group 4. Except for group 1 which was given normal saline, the rest of the groups were given dexamethasone 1 mg/kg, injected every three days, intramuscularly, and combined with retinoic acid, 70 mg/kg per day, for three weeks.

给药方法造模期间除空白对照组和模型对照组给予等容积生理盐水灌胃外,本发明实施例1药物组采用灌胃方式给药,剂量为0.5g/kg,每日三次,对照药物组采用药物仙灵骨葆胶囊颗粒,剂量为0.5g/kg,每日三次。给药三周后,检测扭体次数,然后处死小鼠,小鼠断颈取血,离心取血清,用自动生化分析仪检测S-Ca(血清钙)含量。参见下表1:Administration method During the modeling period, except that the blank control group and the model control group were administered intragastrically with equal volume of normal saline, the drug group of Example 1 of the present invention was administered by intragastric administration, with a dose of 0.5g/kg, three times a day, and the control drug The group used the drug Xianling Gubao Capsules, the dose was 0.5g/kg, three times a day. Three weeks after the administration, the number of writhing was detected, and then the mice were sacrificed. The mice were neck-cut to collect blood, centrifuged to obtain serum, and an automatic biochemical analyzer was used to detect the S-Ca (serum calcium) content. See Table 1 below:

表1Table 1

组别group S-Ca(mmol/L)S-Ca (mmol/L) 扭体次数(次/15分钟)Number of twists (times/15 minutes) 空白对照组Blank control group 2.03±0.172.03±0.17 模型对照组Model control group 4.15±1.034.15±1.03 55±1455±14 实施例1药物组Embodiment 1 drug group 2.47±0.512.47±0.51 13±313±3 对照药物组control drug group 2.85±0.672.85±0.67 21±421±4

从表1可见,模型组与空白组比较,S—Ca大大升高,扭体次数增加,差异明显,说明造模成功。本发明实施例1药物组明显优于对照药物组,即血清中钙含量减少,P<0.01,说明钙流失降低,并且提示本发明药物具备较好的镇痛效果。It can be seen from Table 1 that compared with the blank group, the S-Ca of the model group was greatly increased, and the number of writhing was increased. The difference was obvious, indicating that the modeling was successful. The drug group of Example 1 of the present invention is significantly better than the control drug group, that is, the calcium content in the serum is reduced, P<0.01, indicating that the loss of calcium is reduced, and it is suggested that the drug of the present invention has a better analgesic effect.

实施例3Example 3

临床资料clinical information

从门诊病例中选择骨质疏松患者131例,随机分成治疗组和对照组,治疗组66人,对照组65人,治疗组和对照组所选用的病例中病史、病情、年龄、性别尽量相当。131 patients with osteoporosis were selected from the outpatient cases and randomly divided into treatment group and control group, with 66 patients in the treatment group and 65 patients in the control group.

治疗组给予本发明实施例1制备的蛋白粉,每次3克,每日3次,一个月一个疗程,连续服用2个疗程;The treatment group was given the protein powder prepared in Example 1 of the present invention, 3 grams each time, 3 times a day, one course of treatment a month, and took 2 courses of treatment continuously;

对照组采用常规药物仙灵骨葆胶囊(贵州同济堂制药股份有限公司)。口服,每次3粒,每日2次,分为早、晚温水送服,疗程为两个月。The control group received conventional drug Xianling Gubao Capsules (Guizhou Tongjitang Pharmaceutical Co., Ltd.). Take orally, 3 capsules each time, 2 times a day, divided into morning and evening warm water delivery, the course of treatment is two months.

疗效评定标准Efficacy Evaluation Criteria

诊断标准Diagnostic criteria

①西医诊断标准:参照中国老年学学会骨质疏松委员会骨质疏松诊断标准学科组1999年10月制定的“中国人骨质疏松症建议诊断标准(第二稿)”(中国骨质疏松杂志,2000年第6卷第1期)①Diagnostic criteria of Western medicine: refer to the "Recommended Diagnostic Criteria for Chinese Osteoporosis (Second Draft)" formulated by the Osteoporosis Diagnostic Criteria Group of the Osteoporosis Committee of the Chinese Gerontological Society in October 1999 (Chinese Journal of Osteoporosis, Volume 6, Issue 1, 2000)

②中医诊断标准:按照《中药新药临床研究指导原则》(2002年试行版)的“中药新药治疗骨质疏松症的临床研究指导原则”的评定要求制定。表现为:腰脊疼痛、酸软少力、步履艰难、头目眩晕、不能持重,舌质或偏红或淡,舌苔薄或薄白、脉沉细等症状,骨质疏松症见上述症候者。②Diagnostic criteria of traditional Chinese medicine: formulated in accordance with the assessment requirements of the "Guiding Principles for Clinical Research of New Chinese Medicines for the Treatment of Osteoporosis" in the "Guiding Principles for Clinical Research of New Chinese Medicines" (trial version in 2002). Symptoms: Lumbar spine pain, soreness and weakness, difficulty walking, dizziness, lack of stability, reddish or pale tongue, thin or white tongue coating, deep thready pulse, etc. Osteoporosis sees the above symptoms.

疗效评定标准:Efficacy evaluation criteria:

参照《中国骨质疏松杂志》、《实用骨科学》等评定。Refer to "Chinese Journal of Osteoporosis", "Practical Orthopedics" and other evaluations.

治愈:临床症状、体征消失,功能恢复正常,一年以上不复发;Cure: clinical symptoms and signs disappear, function returns to normal, and no recurrence for more than one year;

显效:临床症状、体征明显减轻,功能基本恢复正常;Significant effect: the clinical symptoms and signs are obviously relieved, and the function basically returns to normal;

有效:临床症状、体征部分减轻;Effective: partial relief of clinical symptoms and signs;

无效:连续治疗30天以上,症状、体征无改变。Ineffective: continuous treatment for more than 30 days, no change in symptoms and signs.

治疗结果见表2:The treatment results are shown in Table 2:

表2Table 2

组别group 治愈cure 显效markedly effective 有效efficient 无效invalid 总有效率total effective rate 治疗组therapy group 2626 22twenty two 1111 77 89%89% 对照组control group 1010 1818 1616 21twenty one 67%67%

可见治疗组相比对照组在治愈率及总有效率方面呈显著性差异。It can be seen that the treatment group is significantly different from the control group in terms of cure rate and total effective rate.

实施例4Example 4

典型病例:Typical cases:

申某,男,63岁。腰痛多年,时轻时重,近一个月病情加重。腰痛难忍,并向双胯及下肢麻木疼痛,不能久站久坐及正常行走活动,腰腿怕冷明显,左腿明显,睡眠欠佳,饮食一般,小便基本正常,大便正常。 给予实施例1制备的鱼胶原蛋白粉,一个疗程后症状减轻,继续服用两个疗程后症状部消失,停药观察至今已经一年多病情没有复发,为治愈。Shen, male, 63 years old. Low back pain for many years, sometimes mild and sometimes severe, and the condition worsened in the past month. Unbearable low back pain, numbness and pain in both hips and lower limbs, unable to stand for long periods of time and walk normally, obvious fear of cold in the waist and legs, obvious left leg, poor sleep, normal diet, normal urination and normal stool. Given the fish collagen powder prepared in Example 1, the symptoms were alleviated after one course of treatment, and the symptoms disappeared after continuing to take two courses of treatment. The disease has not recurred for more than one year after stopping the drug observation, which is a cure.

本发明采用的上述各中药互作配伍,能发挥其协同治病作用,所用中药原料各成分之间具有药效相互交织相互促进和协调效能,经临床验证,适用于骨质疏松症,本申请的中药组合物成本低廉,疗效显著,具有广阔的应用前景。The above-mentioned traditional Chinese medicines used in the present invention are compatible with each other, and can exert their synergistic effect on curing diseases. The ingredients of the traditional Chinese medicine raw materials used have medicinal effects, interweaving, mutual promotion and coordination effects. After clinical verification, they are suitable for osteoporosis. This application The traditional Chinese medicine composition has low cost, remarkable curative effect and broad application prospect.

Claims (1)

1. a kind of Isin glue collagen, it is characterised in that the Isin glue collagen is by fish bone collagen albumen, chondroitin sulfate, Chinese medicine Preparation is according to 10:3:Than being well mixed, the Chinese medicine preparation is prepared 2 weight by the raw material that following weight is matched:
35 parts of ginkgo leaf, 35 parts of prepared rhizome of rehmannia, 35 parts of frankincense, 35 parts of mulberry fruit, 30 parts of deer horn glue,
30 parts of reticulate millettia, 30 parts of Psoralea corylifolia, 30 parts of Poria cocos, 28 parts of the bighead atractylodes rhizome, 28 parts of dandelion,
25 parts of Chinese holly, 25 parts of the Radix Astragali, 25 parts of the fruit of Chinese wolfberry, 25 parts of the fleece-flower root, 22 parts of Chinese yam,
20 parts of Radix Codonopsis, 20 parts of Ligusticum wallichii, 20 parts of wilsonii, 15 parts of the root of kudzu vine, 15 parts of the bark of eucommia,
10 parts of the root of bidentate achyranthes, 10 parts of dried orange peel, 10 parts of Gorgon fruit, 10 parts of barrenwort;
The preparation method of the Chinese medicine preparation comprises the following steps:
Each raw material for standby is weighed according to weight:
(1)Ginkgo leaf, Chinese holly, the Radix Astragali, the fleece-flower root, Radix Codonopsis, Gorgon fruit, barrenwort mixing are taken, plus relative to 3 times of weight of mixture 95% ethanol, refluxing extraction 2 times, 0.5 hour every time, extract solution merged, and was concentrated into the clear cream that density is 1.2g/ml, 80 DEG C of bakings It is dry, it is ground into powder;
(2)Surplus stock is taken, is mixed, plus the decocting of 3 times of weight is boiled twice, 2 hours for the first time, second 1 hour, is merged twice Decoction liquor, it is the medicinal extract of 1.2g/ml that drying under reduced pressure obtains density, is ground into powder;
(3)By step(1)And step(2)The powder of preparation is well mixed to be obtained final product.
CN201510262006.0A 2015-05-21 2015-05-21 A kind of Isin glue collagen and its production method and application Active CN104800836B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510262006.0A CN104800836B (en) 2015-05-21 2015-05-21 A kind of Isin glue collagen and its production method and application

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510262006.0A CN104800836B (en) 2015-05-21 2015-05-21 A kind of Isin glue collagen and its production method and application

Publications (2)

Publication Number Publication Date
CN104800836A CN104800836A (en) 2015-07-29
CN104800836B true CN104800836B (en) 2017-07-04

Family

ID=53686314

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510262006.0A Active CN104800836B (en) 2015-05-21 2015-05-21 A kind of Isin glue collagen and its production method and application

Country Status (1)

Country Link
CN (1) CN104800836B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105053570A (en) * 2015-08-28 2015-11-18 安徽丰原马鞍山生物化学有限公司 Corn gluten meal nutritional solution

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103251671B (en) * 2012-12-28 2015-11-18 北京中研同仁堂医药研发有限公司 A kind of composition and method of making the same containing Chinese medicine increasing bone density
CN104127683A (en) * 2014-08-12 2014-11-05 崔银方 Traditional Chinese medicine composition for treating or preventing female postmenopausal osteoporosis

Also Published As

Publication number Publication date
CN104800836A (en) 2015-07-29

Similar Documents

Publication Publication Date Title
CN104547486A (en) Traditional Chinese medicine preparation for treating anemia and qi-deficiency weakness and preparation process for traditional Chinese medicine preparation
CN104491733A (en) Application of traditional Chinese medicine preparation in preparation of medicines for treating anemia, deficiency of vital energy and debilitation
CN103330837B (en) A traditional Chinese medicine composition for treating postmenopausal women&#39;s osteoporosis
CN104800836B (en) A kind of Isin glue collagen and its production method and application
CN104826095B (en) A kind of chondroitin co-production protein powder and its production method and application
CN102125645B (en) Traditional Chinese medicine preparation for treating osteoporosis
CN105169279A (en) Traditional Chinese medicine composition for treating knee joint bone hyperplasia
CN104524537A (en) Pharmaceutical composition for treating chronic enteritis
CN104800443A (en) Bone setting agent with functions of tonifying kidney and regenerating bone marrow
CN114306497A (en) A traditional Chinese medicine composition, preparation and application for treating osteoporosis of kidney deficiency and blood stasis type
CN101530598B (en) Plaster used for hyperosteogeny
CN1151813C (en) Traditional Chinese medicine composition for curing insomnia
CN105770515A (en) Traditional Chinese medicinal composition for treating prostatitis and preparation method of traditional Chinese medicinal composition
CN105362682A (en) External-use medicine for treating hypomenorrhea
CN104547489A (en) Use of traditional Chinese medicine composition in preparation of medicine for treating comminuted fracture
CN104042839A (en) Traditional Chinese medicine composition for treating tinea versicolor
CN103520684A (en) Traditional Chinese medicine compound for reducing blood sugar
CN109876127A (en) A kind of blood-nourishing angelica capsules and preparation method thereof
CN102727783A (en) Traditional Chinese medicine for preventing and treating diabetes by traditional Chinese medicine foot bath and preparation method thereof
CN104352945A (en) Method for preparing pharmaceutical composition for treating osteoporosis
CN105770815A (en) Folium artemisiae argyi-containing traditional Chinese medicine composition for treating postpartum collapse and preparation method thereof
CN104491114A (en) A new application of traditional Chinese medicine composition
CN104491667B (en) A method of preparing the pharmaceutical composition for union
CN104758539A (en) Traditional Chinese medicine composition for treating debilitation
CN104127709A (en) Traditional Chinese medicinal composition for curing chronic renal insufficiency

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
EXSB Decision made by sipo to initiate substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant
PE01 Entry into force of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A fish collagen protein and its production method and application

Effective date of registration: 20230427

Granted publication date: 20170704

Pledgee: China Postal Savings Bank Co.,Ltd. Feixian Branch

Pledgor: LINYI XINYUHUI BIOLOGICAL TECHNOLOGY CO.,LTD.

Registration number: Y2023980039454

CP03 Change of name, title or address

Address after: No. 9 Xinyuhui Road, Biopharmaceutical Industry Park, Jinyang Village, Huyang Town, Fei County, Linyi City, Shandong Province, 276000

Patentee after: Xinyuhui Biotechnology (Shandong) Co.,Ltd.

Country or region after: China

Address before: Jinyang Village, Huyang Town, Fei County, Linyi City, Shandong Province, 273400

Patentee before: LINYI XINYUHUI BIOLOGICAL TECHNOLOGY CO.,LTD.

Country or region before: China

CP03 Change of name, title or address
PC01 Cancellation of the registration of the contract for pledge of patent right

Granted publication date: 20170704

Pledgee: China Postal Savings Bank Co.,Ltd. Feixian Branch

Pledgor: LINYI XINYUHUI BIOLOGICAL TECHNOLOGY CO.,LTD.

Registration number: Y2023980039454

PC01 Cancellation of the registration of the contract for pledge of patent right
PE01 Entry into force of the registration of the contract for pledge of patent right

Denomination of invention: A fish collagen protein and its production method and application

Granted publication date: 20170704

Pledgee: China Postal Savings Bank Co.,Ltd. Feixian Branch

Pledgor: Xinyuhui Biotechnology (Shandong) Co.,Ltd.

Registration number: Y2025980000078

PE01 Entry into force of the registration of the contract for pledge of patent right